Home / Signaling Pathways / Archive by category "Chromatin/Epigenetics"

Chromatin/Epigenetics

Chromatin and epigenetics signaling pathways involve the regulation of gene expression through modifications to the structure of chromatin, the complex of DNA and proteins in the cell nucleus. These modifications can include changes to the packaging of DNA around histone proteins, as well as chemical modifications to the DNA itself.

Epigenetic changes can affect gene expression without altering the underlying DNA sequence, allowing cells to respond to various signals and environmental cues. These changes can be heritable through cell division and play crucial roles in development, disease, and cell differentiation.

Chromatin remodeling and epigenetic modifications are regulated by a variety of signaling pathways that can be activated by various extracellular signals. These pathways can lead to changes in gene expression by altering the accessibility of DNA to transcription factors and other regulatory proteins.

Understanding the chromatin and epigenetic signaling pathways is essential for unraveling the complexity of gene regulation and can provide insights into disease mechanisms and potential therapeutic targets. Research in this field continues to expand our knowledge of cellular processes and their impact on human health.

Product Search

Image
Triacetyl Resveratrol, B5971, C20H18O6, Cell-permeable resveratrol prodrug
Image
2,4-Pyridinedicarboxylic Acid, B5972, C7H5NO4, Histone LSD inhibitor
Image
2-hexyl-4-Pentynoic Acid, B5969, C11H18O2, Potent and robust HDACs inhibitor
Image
Sanguinarine chloride, B5970, C20H14ClNO4, Inhibitor of PP2C and MKP-1
Image
BML-210(CAY10433), B5968, C20H25N3O2, Novel HDAC inhibitor
Image
UF 010, B5967, C11H15BrN2O, Novel and selective class I HDAC inhibitor
Image
GSK J4 free base, B5959, C24H27N5O2, histone demethylase JMJD3/UTX inhibitor
Image
BG45, B5949, C11H10N4O, Novel HDAC3-selective inhibitor
Image
ACY-241, B5936, C24H26ClN5O3, Selective and orally active HDAC6 inhibitor
Image
Decernotinib(VX-509), B5929, C18H19F3N6O, Selective and orally active JAK3 inhibitor

We are here to help

Whether you are looking to place an order or simply want to learn more about our extensive range of products, we are here to assist you every step of the way.

Quotation request